Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Apr 5, 2023
Open Peer Review Period: Apr 5, 2023 - Apr 10, 2023
Date Accepted: Apr 10, 2023
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Correction: Impact of a Postintensive Care Unit Multidisciplinary Follow-up on the Quality of Life (SUIVI-REA): Protocol for a Multicenter Randomized Controlled Trial

Sharshar T

Correction: Impact of a Postintensive Care Unit Multidisciplinary Follow-up on the Quality of Life (SUIVI-REA): Protocol for a Multicenter Randomized Controlled Trial

JMIR Res Protoc 2023;12:e47929

DOI: 10.2196/47929

PMID: 37058710

PMCID: 10148211

Impact of a Postintensive Care Unit Multidisciplinary Follow-up on the Quality of Life (SUIVI-REA): Protocol for a Multicenter Randomized Controlled Trial

  • Tarek Sharshar

ABSTRACT

50% had a very poor outcome, combining death and moderate to severe impairment of at least one EQ5D dimension” has been corrected to “Therefore, we estimated that at least 50% had a very poor outcome, combining death and severe to extreme impairment of at least one EQ5D dimension”.] [In the sample size section of the manuscript, the passage “The study was then powered to detect a decrease from 50% to 37% of patients with very unfavorable outcome with a power of 90% and a 2-sided 5% alpha risk, assuming this rate would be 50% in the control arm” has been corrected to “The study was then powered to detect a decrease from 50% to 37% of patients with very unfavorable outcome with a power of 80% and a 2-sided 5% alpha risk, assuming this rate would be 50% in the control arm”.] [In the “statistical methods” section of the manuscript, the passage “The 1-year survival rate without major deterioration in QoL (main endpoint, defined as reporting of an extreme problem” level in 1 of the 5 dimensions studied) will be compared between both arms using a piecewise exponential model considering any censorship and the repeated nature of observations, prohibiting the use of conventional methods of analysis of censored data.” has been corrected to “The 1-year survival rate without major deterioration in QoL (main endpoint, defined as reporting of death or a severe to extreme problem” level in 1 of the 5 dimensions studied) will be compared between both arms using a piecewise exponential model considering any censorship and the repeated nature of observations, prohibiting the use of conventional methods of analysis of censored data.”] The correction will appear in the online version of the paper on the JMIR Publications website on [April 15, 2023], together with the publication of this correction notice. Because this was made after submission to PubMed, PubMed Central, and other full-text repositories, the corrected article has also been resubmitted to those repositories. OR (if journal is not indexed in PubMed/PMC): The correction will appear in the online version of the paper on the JMIR Publications website on [June 11, 2021], together with the publication of this correction notice. Because this was made after submission to full-text repositories, the corrected article has also been resubmitted to those repositories.


 Citation

Please cite as:

Sharshar T

Correction: Impact of a Postintensive Care Unit Multidisciplinary Follow-up on the Quality of Life (SUIVI-REA): Protocol for a Multicenter Randomized Controlled Trial

JMIR Res Protoc 2023;12:e47929

DOI: 10.2196/47929

PMID: 37058710

PMCID: 10148211

Per the author's request the PDF is not available.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.